Closing the data loop in AI-driven drug discovery
SponsoredArtificial intelligenceClosing the data loop in AI-driven drug discoveryAI is identifying new therapeutics targets faster than ever. But this speed is exposing physical bottlenecks in the lab, and a need for better data. By MIT Technology Review Insightsarchive pageJuly 27, 2026In partnership withCytiva Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage.
- ▪SponsoredArtificial intelligenceClosing the data loop in AI-driven drug discoveryAI is identifying new therapeutics targets faster than ever.
- ▪But this speed is exposing physical bottlenecks in the lab, and a need for better data.
- ▪By MIT Technology Review Insightsarchive pageJuly 27, 2026In partnership withCytiva Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage.
Hacker News (AI / LLM) files mainly under ai. We currently carry 2,488 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | MIT Technology Review |
| Canonical URL | https://www.technologyreview.com/2026/07/27/1139667/closing-the-data-loop-in-ai-driven-drug-discovery/ |
| Publication time | Mon, 27 Jul 2026 17:02:19 +0000 |
| Retrieval time | 2026-07-27T17:16:33.962Z |
| Last seen | 2026-07-27T17:16:33.962Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | a7K36-ueOfBb · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
SponsoredArtificial intelligenceClosing the data loop in AI-driven drug discoveryAI is identifying new therapeutics targets faster than ever. But this speed is exposing physical bottlenecks in the lab, and a need for better data. By MIT Technology Review Insightsarchive pageJuly 27, 2026In partnership withCytiva Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs anywhere from $1 billion to $2.5 billion, with failure rates upward of 90%.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at MIT Technology Review.
Discussion
0 commentsMore from MIT Technology Review
